Design and statistical issues in multicenter trials of severe head injury
- 1 March 2001
- journal article
- review article
- Published by Taylor & Francis in Neurological Research
- Vol. 23 (2-3) , 190-192
- https://doi.org/10.1179/016164101101198325
Abstract
Multicenter clinical trials are the most powerful agent to evaluate new therapies in medicine, but have failed to impact traumatic brain injury, in which at least 20 such trials have been performed, without a positive result. Such trials need to be carefully planned, with a run-in period to ensure center compliance. Stratification, careful monitoring, adequate sample size, interim analysis and adequate numbers of patients per center are all vital requirements for a useful outcome in such trials.Keywords
This publication has 6 references indexed in Scilit:
- Primary End Points in Phase III Clinical Trials of Severe Head Trauma: DRS Versus GOSJournal of Neurotrauma, 1998
- Sample size in clinical trials with dichotomous endpoints: use of covariablesJournal of Biopharmaceutical Statistics, 1998
- Clinical Neuro-Protection Trials in Severe Traumatic Brain Injury: Lessons from Previous StudiesJournal of Neurotrauma, 1997
- Group Sequential Clinical Trials with Triangular Continuation RegionsBiometrics, 1983
- Quality of Institutional Participation in Multicenter Clinical TrialsNew England Journal of Medicine, 1981